Edwards

Companies Edwards

News Edwards

• The Nobel Prize in Physiology or Medicine 2010 goes to Robert G. Edwards for the development of in vitro fertilization

  Robert Edwards is awarded the 2010 Nobel Prize for the development of human in vitro fertilization (IVF) therapy. His achievements have made it possible to treat infertility, a medical condition afflicting a large proportion of humanity including more than 10% of all couples worldwide. As early as more

• Antisoma's phase III trial of AS1413 completes patient enrolment

  Antisoma plc announces that the ACCEDE phase III trial of AS1413 (amonafide L-malate) in secondary acute myeloid leukaemia (secondary AML) is now fully enrolled. Data from the trial are expected in the first half of 2011, with filings for marketing authorisations to follow if these are positive. more

• Antisoma's AS1413 gains FDA Fast Track status for treatment of secondary acute myeloid leukaemia

  Antisoma plc announced hat the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the Company's novel DNA intercalator, AS1413 (amonafide L-malate), for the treatment of secondary acute myeloid leukaemia (secondary AML). The FDA's Fast Track programme is designed to facil more

White papers Edwards

• Metagenomics Analysis Using the Genome Sequencer FLX System
  

  The Genome Sequencer FLX System from 454 Life Sciences and Roche Applied Science is a versatile sequencing platform suitable for a wide range of applications, including de novo sequencing and assembly of genomic DNA, transcriptome sequencing, small RNA analysis, and amplicon sequencing. The Genome Sequencer FLX is built upon 454 Sequencing technology that enables long read lengths and very high single-read accuracy. One application in which the technology is accelerating the field's understanding is metagenomics. more

Publications Edwards

• Sir Robert Edwards (1925–2013): Creator of the Greatest Happiness

  by Robert Winston more

• [Retrospective] Retrospective: Robert G. Edwards (1925–2013)

  The work of a pioneer of in vitro fertilization led to the first "test-tube baby" and changed the field of human reproductive biology. more

• Dual Pili Post-translational Modifications Synergize to Mediate Meningococcal Adherence to Platelet Activating Factor Receptor on Human Airway Cells

  by Freda E. C. Jen, Matthew J. Warren, Benjamin L. Schulz, Peter M. Power, W. Edward Swords, Jeffery N. Weiser, Michael A. Apicella, Jennifer L. Edwards, Michael P. Jennings Pili of pathogenic Neisseria are major virulence factors associated with adhesion, twitching motility, auto-aggregation, an more

Market studies Edwards

• Leading Anti-Cancer Drugs: World Market Prospects 2011-2021

  What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now. What revenues will cancer treatment markets generate from 2011 to 2021 more

• Acuvax Ltd (ACU) - Financial and Strategic SWOT Analysis Review

  Acuvax Ltd (Acuvax) is a publicly held holding company that is principally engaged in the development of cancer therapies and vaccines. The company develops a range of products that address West Nile virus, pancreatic cancer, dengue, influenza and tick borne encephalitis diseases. Acuvax subsidiarie more

• BPH Corporate Limited (BPH) - Financial and Strategic SWOT Analysis Review

  BPH Corporate Limited (BPH, previously BioPharmica Limited) is engaged in the development and commercialization of biomedical research projects with universities, medical institutes, and hospitals in Australia. The portfolio of the company includes diagnostic testing of infectious disease, brain fun more

Websites Edwards